A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 10715526)

Published in Vaccine on April 14, 2000

Authors

M H Mars1, M C de Jong, J T van Oirschot

Author Affiliations

1: Institute for Animal Science and Health (ID-Lelystad), Department of Mammalian Virology, P.O. Box 65, 8200 AB, Lelystad, The Netherlands. m.h.mars@id.wag-ur.nl

Articles by these authors

Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell (1996) 3.81

Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol (1997) 1.67

Clinically silent rabies infection in (zoo) bats. Vet Rec (1998) 1.58

Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment. Clin Endocrinol (Oxf) (1998) 1.49

Quantification of the transmission of classical swine fever virus between herds during the 1997-1998 epidemic in The Netherlands. Prev Vet Med (1999) 1.40

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Res (2000) 1.21

A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine (1994) 1.21

Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res (2000) 1.20

A long term epidemiological study of bovine viral diarrhoea infections in a large herd of dairy cattle. Vet Rec (1993) 1.19

180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest (1995) 1.16

Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus. J Gen Virol (1996) 1.15

Comparative pathogenesis of three strains of pseudorabies virus in pigs. Microb Pathog (1989) 1.14

Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha. Ann Rheum Dis (2004) 1.13

A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1. J Clin Microbiol (1994) 1.13

Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells. Cell Oncol (2005) 1.08

Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus. J Virol (1997) 1.08

Development of a rapid and sensitive polymerase chain reaction assay for detection of bovine herpesvirus type 1 in bovine semen. J Clin Microbiol (1993) 1.07

A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J Gen Virol (1994) 1.05

Introduction, persistence and fade-out of porcine reproductive and respiratory syndrome virus in a Dutch breeding herd: a mathematical analysis. Epidemiol Infect (2000) 1.05

Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G. J Immunol Methods (1996) 1.04

Some characteristics of four attenuated vaccine virus strains and a virulent strain of Aujeszky's disease virus. Vet Q (1984) 1.03

Spontaneous BHV1 recombinants in which the gI/gE/US9 region is replaced by a duplication/inversion of the US1.5/US2 region. Arch Virol (1999) 1.01

Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J Gen Virol (1986) 0.99

Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions. Vet Q (1985) 0.99

Glycoprotein Erns of pestiviruses induces apoptosis in lymphocytes of several species. J Virol (1997) 0.99

Subcritical endemic steady states in mathematical models for animal infections with incomplete immunity. Math Biosci (2000) 0.98

Modelling the effect of surveillance programmes on spread of bovine herpesvirus 1 between certified cattle herds. Vet Microbiol (2001) 0.98

Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs. Ann Rheum Dis (2004) 0.97

Investigative studies of the dermatitis caused by the larva of the brown-tail moth, Euproctis chrysorrhoea l. (Lepidoptera, Lymantriidae). IV. Further characterization of skin reactive substances. Arch Dermatol Res (1977) 0.97

Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann Rheum Dis (2001) 0.96

Airborne transmission of BHV1, BRSV, and BVDV among cattle is possible under experimental conditions. Vet Microbiol (1999) 0.96

Prevalence and incidence of scrapie in The Netherlands: a questionnaire survey. Vet Rec (1993) 0.96

Investigative studies of the dermatitis caused by the larva of the brown-tail moth (Euproctis chrysorrhoea Linn.) I. Clinical and experimental findings. Arch Dermatol Res (1975) 0.95

Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J Gen Virol (1990) 0.94

In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA. J Rheumatol (1983) 0.94

Factors associated with the introduction of classical swine fever virus into pig herds in the central area of the 1997/98 epidemic in The Netherlands. Vet Rec (2001) 0.94

Growth and sexual maturation in children after kidney transplantation. J Pediatr (1987) 0.94

Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. J Invest Dermatol (1986) 0.93

A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. Vaccine (2001) 0.93

Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. Vaccine (2001) 0.93

Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet (1991) 0.92

Isotype-specific antibody responses in sera and mucosal secretions of calves experimentally infected with bovine herpesvirus 1. Vet Immunol Immunopathol (1995) 0.91

Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus. Vaccine (2004) 0.91

Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor. Virology (1998) 0.91

Transmission of classical swine fever virus within herds during the 1997-1998 epidemic in The Netherlands. Prev Vet Med (1999) 0.91

Expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa. J Invest Dermatol (1992) 0.90

Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet (1994) 0.90

Risk of infection with bovine herpes virus 1 (BHV1): a review. Vet Q (1993) 0.90

A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period. J Gen Virol (1995) 0.89

Effect on milk production of vaccination with a bovine herpesvirus 1 gene-deleted vaccine. Vet Rec (1997) 0.89

Prevalence of antibodies against canine herpesvirus 1 in dogs in The Netherlands in 1997-1998. Vet Microbiol (1999) 0.89

An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine (1995) 0.88

Bone density and body composition in chronic renal failure: effects of growth hormone treatment. Pediatr Nephrol (2000) 0.87

A European inter-laboratory trial to evaluate the reliability of serological diagnosis of bovine herpesvirus 1 infections. Vet Microbiol (1996) 0.87

Equine influenza in the Netherlands during the winter of 1978-1979; antigenic drift of the A-equi 2 virus. Vet Q (1981) 0.87

Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus. Biochemistry (1996) 0.87

Evaluating control strategies for outbreaks in BHV1-free areas using stochastic and spatial simulation. Prev Vet Med (2000) 0.86

A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests. J Clin Microbiol (1997) 0.86

Clinical consequences of a bovine virus diarrhoea virus infection in a dairy herd: a longitudinal study. Vet Q (1994) 0.86

Assessment of the effectiveness of vaccination against pseudorabies in finishing pigs. Am J Vet Res (1995) 0.86

Quantitative investigation of population persistence and recurrent outbreaks of bovine respiratory syncytial virus on dairy farms. Am J Vet Res (1996) 0.86

Epitopes on glycoprotein C of bovine herpesvirus-1 (BHV-1) that allow differentiation between BHV-1.1 and BHV-1.2 strains. J Gen Virol (1999) 0.85

Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency. Arch Dermatol (1996) 0.85

Type XVII collagen (BP180) and LAD-1 are present as separate trimeric complexes. J Invest Dermatol (1999) 0.85

A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine (1997) 0.84

Measurement of isotype-specific antibody responses to Aujeszky's disease virus in sera and mucosal secretions of pigs. Vet Immunol Immunopathol (1992) 0.84

Subdivision of the pestivirus genus based on envelope glycoprotein E2. Virology (1997) 0.84

The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines. Cancer Res (2000) 0.84

Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam. Clin Exp Dermatol (2001) 0.83

Identification of a conserved neutralization site in the first heptad repeat of the fusion protein of respiratory syncytial virus. Arch Virol (1998) 0.83

Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV. J Gen Virol (1998) 0.83

Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. Vet Microbiol (1996) 0.83

Investigative studies of the dermatitis caused by the larva of the brown-tail moth (Euproctis chrysorrhoea Linn.) II. Histopathology of skin lesions and scanning electron microscopy of their causative setae. Arch Dermatol Res (1976) 0.83

Dynamics of pseudorabies virus infections in vaccinated pig populations: a review. Vet Q (1997) 0.83

Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine (1997) 0.82

Use of PCR and immunofluorescence to detect bovine herpesvirus 1 recombinants. J Virol Methods (2001) 0.82

Isotype-specific antibody responses to bovine herpesvirus 1 in sera and mucosal secretions of calves after experimental reinfection and after reactivation. Vet Immunol Immunopathol (1995) 0.82

Subgrouping of bovine respiratory syncytial virus strains detected in lung tissue. Vet Microbiol (1996) 0.82

Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus. Am J Vet Res (1984) 0.82

Bovine respiratory syncytial virus replicates minimally in bovine alveolar macrophages. Arch Virol (1995) 0.82

Airborne transmission of bovine herpesvirus 1 infections in calves under field conditions. Vet Microbiol (2000) 0.81

Antibody responses against the G and F proteins of bovine respiratory syncytial virus after experimental and natural infections. Clin Diagn Lab Immunol (1996) 0.81

Quantitative assessment of the specific CD4+ T lymphocyte proliferative response in bovine herpesvirus 1 immune cattle. Vet Immunol Immunopathol (1994) 0.81

Pemphigus-like eruption induced by d-penicillamine and captopril, in the same patient. Acta Derm Venereol (1988) 0.81

Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP. Cytotechnology (1998) 0.80

Potent interaction of flavopiridol with MRP1. Br J Cancer (1999) 0.80

Bacterial meningitis in 366 children in the Netherlands, 1982-1983. Epidemiology and antibiotic therapy. Tijdschr Kindergeneeskd (1986) 0.80

The histopathology of fiberglass dermatitis in relation to von Hebra's concept of eczema. Contact Dermatitis (1975) 0.80

Investigative studies of the dermatitis caused by the larva of the brown-tail moth, Euproctis chrysorrhoea l. (Lepidoptera, Lymantriidae). III. Chemical analysis of skin reactive substances. Arch Dermatol Res (1977) 0.80

Group B streptococcus: an unusual cause of severe peritonitis in young children treated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis (1991) 0.80

A 4-year-old boy with neurofibromatosis and severe renovascular hypertension due to renal arterial dysplasia. Am J Surg Pathol (1994) 0.80

An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet Microbiol (1996) 0.79

A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments. Vaccine (2000) 0.79

Comparative study on sixteen enzyme-linked immunosorbent assays for the detection of antibodies to bovine herpesvirus 1 in cattle. Vet Microbiol (1993) 0.79

Infectious and surgical complications of childhood continuous ambulatory peritoneal dialysis. Eur J Pediatr (1992) 0.79

Recurrent haemolytic uraemic syndrome. Padiatr Padol (1976) 0.79